NASDAQ · CELH

Celsius Holdings, Inc.

Consumer Defensive · Beverages - Non-Alcoholic

$28.46▲ 0.74% ($0.21)today

As of 12:10 PM ET

52-week

$23.56$66.74

Market cap

$7.28B

What the market price implies · Reverse DCF

To support a price of $28.46, this model requires revenue to grow by 20.19%/yr over the next 10 years, compounded annually.

Historical revenue grew by 68.2%/yr over the past 4 years. The required annual growth rate is 48.00 percentage points lower.

Selected forecast · Base scenario

19.61%/yr · actual 10-year annualized revenue growth

Year 1 growth: 40%

Market-implied · Base operating assumptions + edited margins

20.19%/yr · flat 10-year annualized revenue growth

Reverse DCF solves revenue growth itself using Base operating assumptions and your edited margins. Changing forecast growth alone does not change the implied rate. This is a model-implied requirement, not an analyst forecast.

Valuation

Recommended · Revenue & margin DCF

Price used

$28.46

Estimated value / share

$28.53

Base scenario

This estimate is 0.25% above the price used.

USD · TTM ending 2026-06-30

Latest quarterly growth differs materially from the latest annual pace. It remains an observed growth input; review whether acceleration or a change in the business explains it.

Year 1 growth 40% · Ending margin 7.91% · Discount rate 9.51%

Assumption scenarios, not statistical confidence intervals.

Method, dates & sources

Estimated from future revenue, operating margins, and the investment needed to support them.

Price timestamp: Sep 17, 2026, 4:10 PM UTC
Financial statement period: TTM ending 2026-06-30
Data refreshed: Sep 17, 2026, 4:10 PM UTC · provider

Why this method?

FCFF is positive, but it is still too unstable and too short-lived to anchor even a normalized FCFF DCF. Use revenue and margin assumptions instead of compounding current FCFF.

Is FCFF positive and has it been for 3+ consecutive years? 4 consecutive positive FCFF years are available.

Is FCFF stable (not swinging >30% year to year)? The largest recent FCFF swing is 248.2%. Latest capex is 2.8x the prior median, which points to a capex supercycle that should be normalized first.

Do you have 5+ years of positive FCFF history? Only 4 consecutive positive FCFF years are available.

Price vs Fundamentals

Why The Stock Is Moving

Likely multiple compressionModerate confidence

1Y Price: -49.47%Revenue (TTM): 82.86%FCF (TTM): 119.49%P/FCF: 0th pct

What changed

The stock fell 49.47% over the last year. Revenue grew 82.86% over the trailing twelve months. Operating margin moved from 10.4% to 7.91%. Free cash flow grew 119.49% over the trailing twelve months.

What the market seems to be pricing

Visible fundamentals weakened far less than the stock price, and the shares now sit around the 0th percentile of their historical P/FCF range. That looks more like a rerating of the multiple than a collapse in the business.

What would invalidate this read

This read changes if operating margin (currently 7.91%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.

Performance

Return analysis

Company profile

Celsius Holdings, Inc. is a global enterprise specializing in the development, production, promotion, and distribution of functional beverages and liquid nutritional supplements.

CEOJohn Fieldly

SectorConsumer Defensive

IndustryBeverages - Non-Alcoholic

Employees1,497

IPO dateJan 22, 2007

https://www.celsiusholdingsinc.com

Market multiples

Forward P/E—

EV/EBITDA54.21

Enterprise value$11.03B

Stock splits

Nov 15, 2023↑ Forward

Every 1 shares became 3

+200%

Dec 24, 2009↓ Reverse

Every 20 shares became 1

-95%

Dec 26, 2006↑ Forward

Every 1 shares became 4

+300%

Profitability & growth

Revenue growth10.64%

Gross margin (FY2025)50.39%▲0.2ppvs FY2024

Operating margin (FY2025)18.63%▲7.1ppvs FY2024

ROE4.37%▼0.8ppvs FY2025

Analyst consensus

RatingBuy

Target price$41.83▲46.98%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 5, 2026

Q4 FY26 · EPS est $0.35 · Revenue est $800.03M

View